Actinic keratosis Trials in Spokane, United States
Conditions / Actinic keratosis / Spokane, United States
Clinical trials for Actinic keratosis investigate a range of treatment strategies and patient populations.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02952898 | Study Comparing GDC 695 and Diclofenac Sodium Gel, 3% in Subjects With Actinic Keratoses | COMPLETED | PHASE3 |
| NCT02611804 | A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp | COMPLETED | PHASE3 |
| NCT07144852 | Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities | RECRUITING | — |
| NCT03115476 | A Trial to Compare the Incidence of Squamous Cell Carcinoma (SCC) and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp | TERMINATED | PHASE3 |
| NCT00915551 | A Multi-Center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp) | COMPLETED | PHASE3 |
| NCT01541553 | A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp | COMPLETED | PHASE3 |
| NCT07144345 | Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp | RECRUITING | — |
| NCT01516515 | Efficacy and Safety Phase II Study of SR-T100 to Treat Actinic Keratosis | COMPLETED | PHASE2 |
| NCT00375739 | Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses | COMPLETED | PHASE2 |
| NCT00953732 | A Long Term Follow up Study of Patients Who Have Completed the PEP005-016 or PEP005-025 Studies | COMPLETED | — |